Local Institution - 0351

Taiyuan, Shanxi 030000

0 studies enrolling now · 1 studies all time

What they study most

Pancreatic Ductal Adenocarcinoma

Studies at this site

• A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) — Running, not enrolling